Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral camostat in early ambulatory COVID-19
2020-003475-18Phase 2Completed
- Sponsor
- Ghent University Hospital
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of camostat mesilate in coronavirus disease 2019 (COVID-19), sponsored by Ghent University Hospital. Primary endpoint: Viral load surrogate assessment. Started Sep 2020; status: completed.
02
Drugs
camostat mesilate
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-003475-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003475-18.